Literature DB >> 9350889

Glucose metabolism and insulin secretion in children with cyanotic congenital heart disease.

K H Lundell1, K G Sabel, B O Eriksson, G Mellgren.   

Abstract

The aim of the study was to reveal differences in carbohydrate metabolism in children with cyanotic congenital heart diseases (CHD). Thirteen children with diseases of these kinds were investigated with regard to glucose tolerance and insulin secretion and comparisons were made with healthy controls of the same age. Investigations included an intravenous glucose tolerance test, insulin response to the glucose load in plasma and insulin secretion rate. The results reveal lower fasting glucose levels and signs of a higher insulin secretion rate in the relatively few patients in the CHD group where C-peptide measurements were performed, but no differences in glucose tolerance. The reasons for the differences are unclear, but the chronic increases in circulating catecholamines in combination with the impaired nutritional status of these children with CHD are probably the most important factors. We conclude that these divergences in carbohydrate metabolism should be emphasized in the care of children with CHD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350889     DOI: 10.1111/j.1651-2227.1997.tb14812.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  2 in total

1.  Comparison between serum insulin levels and its resistance with biochemical, clinical and anthropometric parameters in South Indian children and adolescents.

Authors:  G Srinivasa Nageswara Rao; Gurumurthy Prema; Gururajan Priya; Sarasa Barathi Arumugam; V Kirthivasan; R Saibabu; K M Cherian
Journal:  Indian J Clin Biochem       Date:  2010-08-25

2.  Analysis of Cardiovascular Risk Factors in Adults with Congenital Heart Disease.

Authors:  Ju Ryoung Moon; Jinyoung Song; June Huh; I-Seok Kang; Seung Woo Park; Sung-A Chang; Ji-Hyuk Yang; Tae-Gook Jun
Journal:  Korean Circ J       Date:  2015-08-20       Impact factor: 3.243

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.